Total Payments
$1,079
2021 Payments
$38.96
Companies
20
Transactions
70
Medicare Patients
451
Medicare Billing
$33,029
Payment Breakdown by Category
Food & Beverage$1,079 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,079 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $223.88 | 14 | $0 (2020) |
| Novo Nordisk Inc | $151.14 | 12 | $0 (2020) |
| PFIZER INC. | $74.75 | 5 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $72.92 | 4 | $0 (2017) |
| Orexigen Therapeutics, Inc. | $68.55 | 4 | $0 (2017) |
| Shire North American Group Inc | $53.38 | 3 | $0 (2017) |
| Lilly USA, LLC | $52.31 | 4 | $0 (2017) |
| AbbVie Inc. | $49.71 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $46.87 | 3 | $0 (2017) |
| Allergan, Inc. | $45.52 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $38.96 | 2 | AbbVie Inc. ($38.96) |
| 2020 | $73.08 | 5 | AstraZeneca Pharmaceuticals LP ($33.83) |
| 2017 | $967.14 | 63 | AstraZeneca Pharmaceuticals LP ($190.05) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2017 | PFIZER INC. | CHANTIX (Drug), VIAGRA, ELIQUIS | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 04/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY, TRADJENTA | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: DIABETES | ||||||
| 04/11/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: OBESITY | ||||||
| 04/07/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Urology | ||||||
| 04/06/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $39.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2017 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/10/2017 | GlaxoSmithKline, LLC. | FLUARIX (Biological), FLULAVAL, BOOSTRIX | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: VACCINES | ||||||
| 03/08/2017 | GlaxoSmithKline, LLC. | BREO (Drug), ANORO, INCRUSE | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Diabetes | ||||||
| 02/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/25/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: OBESITY | ||||||
| 01/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Diabetes | ||||||
| 01/11/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 161 | 197 | $41,151 | $14,852 |
| 2020 | 9 | 290 | 338 | $51,271 | $18,177 |
Total Patients
451
Total Services
535
Medicare Billing
$33,029
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 91 | $19,929 | $7,281 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,920 | $2,693 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 35 | $5,215 | $1,912 | 36.7% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 28 | 28 | $5,824 | $1,905 | 32.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,663 | $953.61 | 26.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $600.00 | $108.00 | 18.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 87 | $19,053 | $6,292 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 99 | $14,751 | $4,717 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $6,100 | $2,479 | 40.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 28 | 29 | $2,320 | $1,762 | 76.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $4,818 | $1,222 | 25.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 11 | 11 | $2,288 | $911.04 | 39.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 31 | 32 | $810.56 | $545.90 | 67.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 21 | 21 | $1,050 | $193.20 | 18.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 16 | $80.00 | $55.54 | 69.4% |
About Dr. Mary Welp, M.D
Dr. Mary Welp, M.D is a Family Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902855646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Welp, M.D has received a total of $1,079 in payments from pharmaceutical and medical device companies, with $38.96 received in 2021. These payments were reported across 70 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,079).
As a Medicare-enrolled provider, Welp has provided services to 451 Medicare beneficiaries, totaling 535 services with total Medicare billing of $33,029. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Midlothian, TX
- Active Since 05/09/2006
- Last Updated 01/18/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902855646
Products in Payments
- FARXIGA (Drug) $223.88
- Victoza (Drug) $113.33
- CONTRAVE (Drug) $68.55
- JARDIANCE (Drug) $58.44
- INVOKANA (Drug) $46.87
- TRULICITY (Drug) $37.27
- Omnipod (Device) $36.58
- VRAYLAR (Drug) $35.67
- TRIGEN InterTAN (Device) $32.97
- VYVANSE (Drug) $32.12
- Saxenda (Drug) $26.48
- CYCLOSET (Drug) $24.95
- BREO (Drug) $23.97
- MYDAYIS (Drug) $21.26
- Myrbetriq (Drug) $19.34
- PRALUENT (Drug) $18.57
- LYRICA (Drug) $18.28
- LINZESS (Drug) $17.31
- UBRELVY (Drug) $17.31
- CHANTIX (Drug) $16.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Family Medicine $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Family Medicine $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
Family Medicine $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Family Medicine $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Family Medicine $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759
Family Medicine $12,759